Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 258 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2923 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
21 (8%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2020-03-12 | 2020-04-09 | 108598 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-03-26 | 2020-04-09 | 109610 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Resolved | 2020-04-16 | 2020-06-04 | 112373 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-05-01 | 2020-06-04 | 113776 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2020-05-01 | 2020-06-11 | 113788 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Resolved | 2020-07-09 | 2020-10-30 | 119886 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-08-20 | 2020-12-17 | 122693 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2020-08-27 | 2020-09-25 | 123084 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-09-17 | 2020-12-17 | 124471 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-11-19 | 2021-01-21 | 128609 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2021-06-24 | 2022-02-05 | 141457 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2021-07-29 | 2022-02-05 | 143239 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2021-08-27 | 2021-11-18 | 144707 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2021-10-21 | 2021-11-18 | 147696 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2022-03-31 | 2022-08-19 | 157642 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2022-06-03 | 2022-12-08 | 161928 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2022-06-09 | 2023-01-18 | 162271 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Resolved | 2022-08-18 | 2025-04-25 | 167162 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-01-19 | 2023-01-26 | 181611 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-06-08 | 2023-10-04 | 194080 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CAPTOPRIL | 25MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258556 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14052 |
| TEVA-CEPHALEXIN | 500MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125979 |
| TEVA-CEPHALEXIN | 250MG | TABLET | Discontinued | 2020-10-08 | 2020-10-09 | 125982 |
| TEVA-CILAZAPRIL/HCTZ | 12.5MG 5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258759 |
| TEVA-CIPROFLOXACIN | 500MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14049 |
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| TEVA-CLARITHROMYCIN | 500MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117526 |
| TEVA-CLARITHROMYCIN | 250MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117529 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Discontinued | 2025-04-25 | 2025-04-25 | 255815 |
| TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
| TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
| TEVA-CLONAZEPAM | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64929 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |